Symptoma
Symptoma provides differential diagnoses by analyzing user-reported symptoms with artificial intelligence to identify and rank possible diseases, including COVID-19.
Key Features:
- Extensive Disease Database: Differentiates among more than 20,000 diseases with reported accuracy exceeding 90%.
- High COVID-19 Identification Accuracy: Accurately distinguished COVID-19 in 96.32% of evaluated instances and identified all infected individuals when presented with three characteristic signs using symptoms and risk factors alone.
- AI-based Diagnostic Algorithm: Uses an artificial intelligence algorithm to analyze symptoms against its disease database and generate probability-ranked diagnoses.
- Free-text Input and Disease-specific Follow-up Questions: Collects symptom data via free-text input and refines responses using targeted follow-up questions for specific diseases.
- Superior to Simple Questionnaires: Demonstrates higher diagnostic accuracy compared with basic yes-no symptom questionnaires.
- Multilingual Support: Operates in 36 languages.
Scientific Applications:
- Prescreening: Serves as a prescreening mechanism to reduce burden on telephone hotlines during epidemics and high call volumes.
- Clinical Decision Support: Provides differential diagnoses to assist healthcare professionals in prioritizing and making clinical decisions.
- Public Health Surveillance: Supports identification of COVID-19 cases for use in monitoring and controlling infectious disease spread.
Methodology:
Symptoma employs an artificial intelligence-based algorithm that analyzes entered symptoms against its extensive disease database and outputs a probability-ranked list of potential diagnoses; it collects symptom data via free-text input and applies disease-specific follow-up questions to refine the diagnostic ranking.
Topics
Details
- Added:
- 1/18/2021
- Last Updated:
- 2/25/2021
Operations
Publications
Martin A, Nateqi J, Gruarin S, Munsch N, Abdarahmane I, Knapp B. An artificial intelligence-based first-line defence against COVID-19: digitally screening citizens for risks via a chatbot. Unknown Journal. 2020. doi:10.1101/2020.03.25.008805.